Use este identificador para citar ou linkar para este item: http://repositorio.ufla.br/jspui/handle/1/28496
Registro completo de metadados
Campo DCValorIdioma
dc.creatorAssis, Tamiris M.-
dc.creatorMancini, Daiana T.-
dc.creatorRamalho, Teodorico C.-
dc.creatorCunha, Elaine F. F. da-
dc.date.accessioned2018-01-26T16:03:40Z-
dc.date.available2018-01-26T16:03:40Z-
dc.date.issued2014-
dc.identifier.citationASSIS, T. M. et al. In silico study of leishmania donovani α-β tubulin and inhibitors. Journal of Chemistry, [S. l.], v. 2014, p. 1-8, 2014. doi: http://dx.doi.org/10.1155/2014/492579.pt_BR
dc.identifier.urihttp://repositorio.ufla.br/jspui/handle/1/28496-
dc.description.abstractLeishmania donovani is a parasite that causes visceral leishmaniasis, a severe form of leishmaniasis that affects vital organs. An important target for the treatment of this disease is the protein α-β tubulin, which was modeled in this paper and proposed as a target for the treatment of visceral leishmaniasis. Two classes of compounds were studied, dinitroanilines and oxadiazoles. According to the docking results, dinitroanilines interact better with the L loop domain and oxadiazoles interact better with the colchicine domain.pt_BR
dc.languageen_USpt_BR
dc.publisherHindawi Publishing Corporationpt_BR
dc.rightsacesso abertopt_BR
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceJournal of Chemistrypt_BR
dc.subjectVisceral leishmaniasispt_BR
dc.subjectDinitroanilinespt_BR
dc.subjectOxadiazolespt_BR
dc.subjectLeishmaniose visceralpt_BR
dc.subjectDinitroanilinaspt_BR
dc.titleIn silico study of leishmania donovani α-β tubulin and inhibitorspt_BR
dc.typeArtigopt_BR
Aparece nas coleções:DQI - Artigos publicados em periódicos

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_In silico study of leishmania donovani α-β tubulin and inhibitors.pdf2,41 MBAdobe PDFVisualizar/Abrir


Este item está licenciada sob uma Licença Creative Commons Creative Commons